TBPH stock news · Theravance Biopharma, Inc.
Get alerts for TBPH
Follow Theravance Biopharma, Inc. (TBPH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TBPHFree on the App Store and Google Play, or on the web.
Theravance Biopharma, Inc. has signed an important agreement and plans to leave the Nasdaq.
NeutralSale for $17 plus a contingent right gives shareholders cash but no clear premium; this leaves TBPH neutral for investors who held it.
Theravance Biopharma, Inc. asked its shareholders to vote on important issues.
NeutralTheravance filed an 8-K reporting a Sept 18 shareholder vote on a proposed merger; the filing gives no vote results, so I read this as neutral for TBPH.
Theravance Biopharma, Inc. shares updates about its merger with Zymeworks and legal issues with shareholders.
NeutralTheravance filed a merger proxy and faces lawsuits; it will supplement disclosures. Those facts cancel each other, so the report does not change how I read Theravance today.